The role of carnitine in normal and altered fatty acid metabolism

C Hoppel - American Journal of Kidney Diseases, 2003 - Elsevier
Carnitine is a low-molecular-weight compound obtained from the diet that also is
biosynthesized from the essential amino acids lysine and methionine. Carnitine has been …

Supplementation of L-carnitine in athletes: does it make sense?

H Karlic, A Lohninger - Nutrition, 2004 - Elsevier
Studies in athletes have shown that carnitine supplementation may foster exercise
performance. As reported in the majority of studies, an increase in maximal oxygen …

Red blood cell survival in chronic renal failure

J Ly, R Marticorena, S Donnelly - American Journal of Kidney Diseases, 2004 - Elsevier
Background: A decrease in the lifespan of erythrocytes has been accepted universally as
one of the contributory factors to anemia in patients with chronic renal failure. This …

Carnitine and hemodialysis

G Bellinghieri, D Santoro, M Calvani… - American journal of …, 2003 - Elsevier
Carnitine, gamma-trimethyl-beta-hydroxybutyrobetaine, is a small molecule widely present
in all cells from prokaryotic to eukaryotic. It is an important element in the beta-oxidation of …

Carnitine metabolism and deficit-when supplementation is necessary?

A Evangeliou, D Vlassopoulos - Current pharmaceutical …, 2003 - ingentaconnect.com
Carnitine is an ammo acid derivative found in high energy demanding tissues (skeletal
muscles, myocardium, the liver and the suprarenal glands). It is essential for the …

Significance of levocarnitine treatment in dialysis patients

H Takashima, T Maruyama, M Abe - Nutrients, 2021 - mdpi.com
Carnitine is a naturally occurring amino acid derivative that is involved in the transport of
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …

History of L-carnitine: implications for renal disease

M Matera, G Bellinghieri, G Costantino, D Santoro… - Journal of Renal …, 2003 - Elsevier
L-Carnitine (LC) plays an essential metabolic role that consists in transferring the long chain
fatty acids (LCFAs) through the mithocondrial barrier, thus allowing their energy-yielding …

Levocarnitine and dialysis: a review

B Schreiber - Nutrition in clinical practice, 2005 - Wiley Online Library
Among the various metabolic abnormalities documented in dialysis patients are
abnormalities related to the metabolism of fatty acids. Aberrant fatty‐acid metabolism has …

[HTML][HTML] L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin

M Malaguarnera, M Vacante, M Giordano… - World journal of …, 2011 - ncbi.nlm.nih.gov
AIM: To evaluate the efficacy of L-carnitine on alleviating anemia, thrombocytopenia and
leukopenia, and minimizing dose reductions in patients with chronic hepatitis C virus (HCV) …

Pharmacological use of L-carnitine in uremic anemia: has its full potential been exploited?

M Bonomini, V Zammit, CD Pusey, A De Vecchi… - Pharmacological …, 2011 - Elsevier
Anemia is one of the most frequent complications of kidney failure and a common cause of
morbidity in dialysis patients. A number of clinical studies have suggested that l-carnitine …